During the past decade, UCLA General Clinical Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCLA General Clinical Research Center" are "Depression" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Epilepsy" (1 trials) and "Inflammation" (1 trials). Many other conditions were trialed in "UCLA General Clinical Research Center" in a lesser frequency.

Most popular intervention types in "UCLA General Clinical Research Center" are "Drug" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Endotoxin" (1 trials), "High Dose Fish Oil" (1 trials), "Low Dose Fish Oil" (1 trials) and "Magnesium Citrate: a total of 500 mg elemental magnesium" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA General Clinical Research Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UCLA General Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UCLA General Clinical Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA General Clinical Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".